• Policy & Insight

How Secure Data Environments can help drive advances in health data research

NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer. NHS England is changing the way that researchers access health data in England by moving to a network of Secure Data Environments. With proper government support, it can help researchers find better ways to prevent, diagnose and treat cancer.

8 August 2024

• Health & Medicine

NICE recommends pembrolizumab for advanced stomach cancers

The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer. The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer.

7 August 2024

• Science & Technology

SU2C gives £7.5m more to improve treatments for children’s and young people’s cancers

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

7 August 2024

• Health & Medicine

Bacon, sandwich ham and salami: How does processed and red meat cause cancer and how much matters?

How does bacon cause cancer? Research shows that moderate processed and red meat eating increases bowel cancer risk. How does bacon cause cancer? Research shows that moderate processed and red meat eating increases bowel cancer risk.

1 August 2024

• For Researchers

Exploring the promise of decentralised cancer clinical trials

Can decentralised trials become mainstream for cancer? The benefits can be manifold, but so can the challenges... Can decentralised trials become mainstream for cancer? The benefits can be manifold, but so can the challenges...

31 July 2024

• For Researchers

The great escape artist – how tracking co-evolution could improve immunotherapy

We need to understand how tumours and the immune system co-evolve to target cancer cells at their most vulnerable... We need to understand how tumours and the immune system co-evolve to target cancer cells at their most vulnerable...

24 July 2024

• Policy & Insight

Why a focus on waiting time targets may neglect the poorest cancer patients

Naser Turabi, our director of evidence and implementation, explains why ensuring equitable access to cancer treatment is so crucial. Naser Turabi, our director of evidence and implementation, explains why ensuring equitable access to cancer treatment is so crucial.

22 July 2024

• Health & Medicine

New ‘take at home’ pill recommended for advanced prostate cancer

More than 40,000 people could benefit from a new oral hormone therapy for people with certain types of prostate cancer. More than 40,000 people could benefit from a new oral hormone therapy for people with certain types of prostate cancer.

19 July 2024

• Policy & Insight

King’s Speech reintroduces legislation to raise the age of sale of tobacco

Today, plans to reintroduce a Bill to progressively raise the age of sale of tobacco products were announced in the first King’s Speech of this new UK Government Today, plans to reintroduce a Bill to progressively raise the age of sale of tobacco products were announced in the first King’s Speech of this new UK Government

17 July 2024

• For Researchers

Introducing our new clinical research funding

Head of clinical research Dr Graham Cadwallader, tells us about the bold changes we are making to the way we fund clinical research... Head of clinical research Dr Graham Cadwallader, tells us about the bold changes we are making to the way we fund clinical research...

17 July 2024